“Atropisomeric” Drugs: Basic Concept and Example of Application to Drug Development

Journals Menu

Follow SCIRP

ISSN Print: 2157-9423
ISSN Online: 2157-9431
www.scirp.org/journal/pp
E-mail: pp@scirp.org

"“Atropisomeric” Drugs: Basic Concept and Example of Application to Drug Development"
written by Robert B. Raffa, Joseph V. Pergolizzi Jr., Robert Taylor Jr.,
published by Pharmacology & Pharmacy, Vol.11 No.1, 2020

has been cited by the following article(s):

No relevant information.

[1]	Atropisomerism transforming anti‐cancer drug discovery Chemical Biology & Drug Design, 2023 DOI:10.1111/cbdd.14155

[2]	Atropisomerism transforming anti‐cancer drug discovery Chemical Biology & Drug Design, 2023 DOI:10.1111/cbdd.14155

[3]	High-Level Data Fusion Enables the Chemoinformatically Guided Discovery of Chiral Disulfonimide Catalysts for Atropselective Iodination of 2-Amino-6-arylpyridines Journal of the American Chemical Society, 2022 DOI:10.1021/jacs.2c08820

[4]	Atropisomerism transforming anti‐cancer drug discovery Chemical Biology & Drug Design, 2022 DOI:10.1111/cbdd.14155

[5]	BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe Journal of Medicinal Chemistry, 2022 DOI:10.1021/acs.jmedchem.2c00441

Follow SCIRP